United Therapeutics Corporation Payments to Acquire Equity Method Investments
United Therapeutics Corporation (UTHR) reported Payments to Acquire Equity Method Investments of $2.10 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2019-02-27
- United Therapeutics Corporation payments to acquire equity method investments for the quarter ending 2016-12-31 was $0.00.
- United Therapeutics Corporation payments to acquire equity method investments for the quarter ending 2016-09-30 was $0.00.
- United Therapeutics Corporation payments to acquire equity method investments for fiscal 2016 was $2.10M.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $2.10M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $2.10M 10-Q · filed 2017-10-25 | ||
| 2016-06-30 | $2.10M 10-Q · filed 2017-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |